Schallenberger Mark A. reported grant involving 450,000 shares of Xtant Medical Holdings, Inc. at $0.00 for $0 on Aug 15, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Operating Officer
Chief Operating Officer
Filed Aug 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
450,000Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
1,113,157Direct
Trade date
Aug 15, 2026Grant
Filed
Aug 18, 2026, 6:02 PM ET3-day reporting delay
Accession
0001960742-26-000002Code A · Transaction 4262
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 15, 2026Tax withholding7,070$0.31−$2,191.70Trade 4263
2 transaction rows in this filing. Joint filers share the same rows.

XTNT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
XTNT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +33%1w ago +33%1d ago −9.1%
Returns since7d −6.1%30d −3%90d180d1y

Footnotes in full

F1: These shares will vest with respect to 112,500 shares on each of August 15, 2027, August 15, 2028, August 15, 2029, and August 15, 2030 pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock. F2: Includes an aggregate of 944,758 shares issuable upon vesting and settlement of restricted stock unit (RSU) awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and 22,250 shares issuable upon vesting and settlement of RSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting dates. F3: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.